• Fludarabine: From DNA Synthesis to Assay Design

  2026-09-02

  Explore how Fludarabine, a DNA synthesis inhibitor, connects purine-analog biochemistry with rigorous oncology assay design. This guide adds a genotype-aware interpretation framework inspired by Waldenström macroglobulinemia therapy-sequencing research.

• Lanabecestat (AZD3293): Smarter BACE1 Assays

  2026-09-01

  Explore how Lanabecestat (AZD3293) supports mechanistically informed BACE1 assays, from amyloid-beta production inhibition to functional neuronal readouts. This article translates key findings from Satir et al. into practical experimental design and interpretation guidance.

• Propidium Iodide Workflows for Granulosa Cell Assays

  2026-09-01

  Propidium iodide converts membrane damage and DNA content into measurable fluorescence, making it a practical complement to CCK-8, Western blotting, and Annexin V in granulosa-cell research. This workflow translates AMH–SMAD4 findings in PCOS rats into actionable viability, apoptosis, and cell-cycle experiments.

• MK 0893: Glucagon Receptor Antagonist Workflows

  2026-08-31

  Build more interpretable GCGR binding and cAMP assays with MK 0893, a potent competitive reversible antagonist suited to receptor pharmacology and glucose-regulation studies. The workflow connects nanomolar cellular activity with practical solvent handling, selectivity controls, and translational testing in hGCGR animal models.

• Mitomycin C: From DNA Damage to Immune-Ready Models

  2026-08-31

  Mitomycin C is more than a conventional cytotoxic benchmark. As an antitumor antibiotic that forms covalent DNA adducts, it gives translational researchers a controllable way to study DNA replication inhibition, apoptosis priming, and TRAIL sensitization. This article connects those established applications with a recent HCC immunotherapy study while clearly separating validated evidence from hypothesis-generating opportunities.

• Triterpene Prodrug Enables Self-Boosted OSCC Therapy

  2026-08-30

  This 2024 ACS Applied Materials & Interfaces study developed a carrier-free, self-assembled prodrug from glycyrrhetinic acid and ginsenoside Rh2 for oral squamous cell carcinoma. Its ROS-responsive design couples tumor-associated uptake with a feedback mechanism in which glycyrrhetinic acid amplifies oxidative stress and promotes further drug release, offering a preclinical strategy for reducing reliance on complex nanocarriers.

• QRICH1, HMGB1, and HBV-Driven Liver Fibrosis

  2026-08-29

  The 2025 Immunobiology study identifies QRICH1 as an endoplasmic reticulum stress effector that strengthens HBV-associated HMGB1 transcription, acetylation-related translocation, and secretion. By integrating a chronic rcccDNA mouse model with clinical hepatitis B specimens, the work connects viral stress signaling to inflammatory and fibrotic liver injury while highlighting important limits on causal interpretation.

• Amiloride (MK-870) in Trafficking-Aware Assays

  2026-08-28

  Amiloride (MK-870) can serve as a mechanistic perturbation in ion-transport and uptake studies. This article connects its ENaC, PC2, and uPAR activities with emerging ER-targeted nanovaccine research while emphasizing controls that prevent overinterpretation.

• Cy3 TSA Fluorescence System Kit Workflow

  2026-08-28

  Learn how to apply the Cy3 TSA Fluorescence System Kit to sensitive IHC, ICC, and ISH workflows, including spatial studies of NET-DNA, CCDC25, and IL-22 in intestinal repair. The guide combines practical assay design, executable starting conditions, quantitative imaging advice, and troubleshooting for challenging low-abundance targets.

• NPT1-Mediated p-Aminohippuric Acid Transport

  2026-08-27

  The 2000 reference study provided the first molecular evidence that human renal apical NPT1 transports p-aminohippuric acid (PAH), resolving an important gap in the model of organic anion secretion. Using radiotracer uptake in hNPT1-transfected HEK293 cells, the authors also identified uric acid, benzylpenicillin, faropenem, and estradiol-17β-glucuronide as accepted substrates, linking NPT1 to renal handling of endogenous compounds and β-lactam drugs.

• Chlorpromazine HCl: Applied Research Workflows

  2026-08-27

  Chlorpromazine HCl gives researchers a versatile dopamine receptor antagonist for paired neuropharmacology and host-directed immunity experiments. This workflow translates receptor pharmacology, neuronal signaling, ROS, lysosomal activity, and autophagy into practical assay designs while separating established evidence from testable extensions.

• Vacuolin-1 Workflows for Lysosomal Exocytosis

  2026-08-26

  Use Vacuolin-1 to separate calcium-triggered lysosomal secretion from broader membrane-trafficking effects in cell-based assays. This guide translates findings from an MPS IVA cartilage model into practical β-hexosaminidase, Lamp-1, membrane-repair, and signaling workflows, with troubleshooting guidance for reproducible inhibition.

• ARv7 and Enzalutamide in Triple-Negative Breast Cancer

  2026-08-26

  This 2025 study connects androgen receptor variant 7 (ARv7) expression with adverse outcomes in triple-negative breast cancer (TNBC) and examines how Enzalutamide and EPI-001 alter metastatic and epithelial–mesenchymal transition markers. Its combined patient, TCGA, and MDA-MB-231 analyses support ARv7 as a prognostic candidate and provide a mechanistic framework for androgen receptor-mediated pathway modulation beyond prostate cancer.

• Azithromycin Workflows for Infection and Resistance

  2026-08-25

  Build reproducible Azithromycin assays for bacterial infection research, resistance screening, and translational PK/PD planning. This guide combines solvent and stability controls with a practical workflow inspired by gamithromycin exposure-response analysis, while clearly separating validated evidence from assay-development recommendations.

• Amiloride (MK-870): Workflow and Assay Guide

  2026-08-25

  Use Amiloride (MK-870) to dissect epithelial sodium transport, uPAR-linked signaling, and ion-dependent cellular phenotypes with a practical, control-rich workflow. Its value is equally clear when it produces no antiviral-entry effect, helping distinguish sodium-channel modulation from clathrin-dependent uptake.

8516 records 1/568 page Next 12345 下5页 Last page